High Expression and Clinical Significance of Elafin in Colorectal Cancer

Table 4

Correlation of Elafin expression with clinicopathological characteristics of colorectal cancer patients.

Clinical feature	IHC					TCGA
	Total ()	High (%)	Low (%)		value	Total ()	PI3 levels		value
Age				0.885	0.347			0.086	0.931
<65	36	26 (72.2)	10 (27.8)			167
≥65	52	42 (80.8)	10 (19.2)			271
Gender				0.018	0.892			-0.799	0.425
Male	50	39 (77.6)	11 (22.4)			230
Female	38	29 (76.3)	9 (23.7)			208
Clinical stage				4.849	0.028			0.617	0.537
I-II	41	36 (87.8)	5 (12.2)			248
III-IV	47	32 (68.1)	15 (31.9)			190
Tumor invasive				0.097	0.755			-0.183	0.855
T1-T3	64	50 (78.1)	14 (21.9)			384
T4	24	18 (75.0)	6 (25.0)			54
Lymph node metastasis				3.26	0.071			0.390	0.697
N0	42	36 (85.7)	6 (14.3)			257
N1-N2	46	32 (69.6)	14 (30.4)			281
Distant metastasis				0.901	0.343			0.150	0.881
M0	83	65 (78.3)	18 (21.7)			327
M1	5	3 (60.0)	2 (40.0)			64

Continuous variables are presented as the . IHC: immunohistochemistry; TCGA: The Cancer Genome Atlas.